In evaluating generic entry opportunities many factors must be considered. DrugPatentWatch has comprehensive resources to aid in evaluating patent and regulatory constraints, and those are described in further detail in…
Posts published in “Tips, Tricks, and Case Studies”
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers by giving them 180 days of generic market exclusivity (see…
Pharmaceutical Formulary Management: Anticipating generic entry, identifying first generic entrants, and projecting drug price drops
0
Pharmaceutical formulary managers have a pressing need to manage their formulary budgets. Anticipating when drugs will face loss-of-exclusivity — when their key patents will expire — is an essential first-step…
Anticipate the Future Global biopharmaceutical markets face constant change. To remain competitive you need to anticipate what’s next. We understand and work together with you to help you make better…
Patents filed since 1995 last for 20 years from the date of patent application filing. This is true for “utility” patents, but the terms for certain other, less common types…
The theoretical construct of what happens when drug patents expire is simple and appealing (to consumers, anyway). A name brand drug patent expires, generics are waiting in the wings to…
Improve Your Litigation Success, Predict Settlement Terms, and Write Better Patents by Analyzing Patent Challenges
0
Litigation related to drug patents, whether it be direct patent challenges, contract disputes, or other cases, can provide direct intelligence (through disclosures of competitive intelligence) or indirect intelligence through exposure…
Disclosure: the majority of the companies mentioned below are, or have been, clients of DrugPatentWatch Drug patent litigation can be used for many aspect of biopharmaceutical business strategy. Many parties…
Which Company Will be the First to Launch a Generic Drug? There are many reasons to find out which companies will be first to launch generic drugs. Payers need to…